Induction of chondrogenesis in neural crest cells by mutant fibroblast growth factor receptors. (Q50335609)

5 March 2018

title

Induction of chondrogenesis in neural crest cells by mutant fibroblast growth factor receptors. (English)

1 reference

5 March 2018

main subject

cartilage development

1 reference

2

1 reference

5 March 2018

Andrew J Copp

series ordinal

3

1 reference

5 March 2018

author name string

Anita Petiot

series ordinal

1

1 reference

5 March 2018

Chi-Tsung Joseph Chan

series ordinal

4

1 reference

5 March 2018

publication date

1 June 2002

1 reference

5 March 2018

published in

Developmental Dynamics

1 reference

5 March 2018

volume

224

1 reference

5 March 2018

issue

2

1 reference

5 March 2018

page(s)

210-221

1 reference

5 March 2018

Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand

cites work

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

The origins of the neural crest. Part I: embryonic induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Fibroblast growth factor receptors: lessons from the genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Molecular control of neural crest formation, migration and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Sutural biology and the correlates of craniosynostosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Patterning of neural crest derivatives in the avian embryo: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Blocking endogenous FGF-2 activity prevents cranial osteogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Origins of neural crest cell diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Sparking new frontiers: using in vivo electroporation for genetic manipulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

FGFR activation in skeletal disorders: too much of a good thing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Sox9 is required for cartilage formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Chapter 10 Manipulating Gene Expression with Replication--Competent Retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDVDY.10102

21 January 2018

Identifiers

DOI

10.1002/DVDY.10102

1 reference

5 March 2018

PubMed ID

12112473

1 reference

5 March 2018